How to decrease p27Kip1 levels during tumor development

Andrew Koff1

  • 1Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA. a-koff@ski.mskcc.org

Cancer Cell
|February 14, 2006
PubMed

Insights

The tumor suppressor p27Kip1’s levels decrease in cancer through unknown posttranscriptional mechanisms. New mouse models reveal surprising insights into the pathways controlling p27Kip1 turnover during tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • p27Kip1 is a critical cyclin-dependent kinase inhibitor and tumor suppressor.
  • High p27Kip1 levels correlate with favorable prognosis in human cancers.
  • Decreased p27Kip1 is linked to increased tumor incidence in mouse models.

Purpose of the Study:

  • To investigate the largely unknown posttranscriptional mechanisms regulating p27Kip1 levels in cancer.
  • To determine which posttranscriptional regulatory pathways are essential for p27Kip1 turnover during tumor development.

Main Methods:

  • Utilized a series of allelic mouse models with specific p27Kip1 mutations.
  • Examined the impact of these mutations on different posttranscriptional regulatory pathways.
  • Assessed the necessity of these pathways for p27Kip1 turnover in the context of tumor development.

Main Results:

  • Identified specific posttranscriptional regulatory pathways influencing p27Kip1 stability.
  • Demonstrated that certain pathways are crucial for p27Kip1 turnover during tumorigenesis.
  • Observed surprising and unexpected results regarding the role of these pathways.

Conclusions:

  • p27Kip1 regulation in cancer primarily occurs posttranscriptionally, not via gene mutation or silencing.
  • The study highlights novel pathways involved in p27Kip1 degradation, offering new therapeutic targets.
  • Further research using these mouse models will elucidate the precise mechanisms of p27Kip1 regulation in cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...